日本語View as Markdown

Hydrogen-rich saline protects myocardium against ischemia/reperfusion injury in rats.

水素豊富生理食塩水によるラット心筋虚血再灌流障害に対する保護効果

animal study injection / infusion positive

Abstract

This rat study examined whether intraperitoneally administered hydrogen-rich saline could reduce cardiac damage following 30 minutes of left anterior descending coronary artery occlusion and 24 hours of reperfusion. Animals receiving hydrogen-rich saline prior to reperfusion showed significantly lower plasma and myocardial malondialdehyde (MDA) levels, reduced 8-hydroxydeoxyguanosine (8-OHdG) in the area at risk, suppressed caspase-3 activity, decreased cardiomyocyte apoptosis, and smaller infarct size compared with controls. Cardiac functional parameters—including left ventricular systolic pressure, diastolic pressure, and the maximum rates of pressure rise and fall (±dP/dt)—were also markedly improved at 24 hours post-reperfusion. These findings indicate that hydrogen-rich saline administration before reperfusion confers measurable cardioprotection in this experimental model.

Mechanism

Hydrogen-rich saline is proposed to scavenge reactive oxygen species, thereby reducing lipid peroxidation (evidenced by lower MDA and 8-OHdG levels) and suppressing caspase-3-mediated apoptotic signaling, collectively limiting cardiomyocyte death during reperfusion.

Bibliographic

Authors
Sun Q, Kang Z, Cai J, Liu W, Liu Y, Zhang JH, et al.
Journal
Exp Biol Med (Maywood)
Year
2009
PMID
19596825
DOI
10.3181/0812-RM-349

Tags

Disease:虚血再灌流障害 心筋梗塞 Delivery:点滴投与 Mechanism:アポトーシス抑制 ヒドロキシルラジカル消去 脂質過酸化 酸化ストレス 活性酸素種

Delivery context

Intravenous hydrogen-saline infusion is a clinic-only route and is not viable for everyday self-administration. For routine hydrogen intake, inhalation is the most practical route, but inhalation carries explosion risk and concentration matters (empirical LFL of 10%; high-concentration 66% / 100% devices are not recommended).

Safety notes

Intravenous hydrogen-saline infusion is a clinic-only route and is not viable for everyday self-administration. For routine hydrogen intake, inhalation is the most practical route, but inhalation carries explosion risk and concentration matters (empirical LFL of 10%; high-concentration 66% / 100% devices are not recommended).

See also:

Other papers on the same disease / condition

Cite as: H2 Papers — PMID 19596825. https://h2-papers.org/en/papers/19596825
Source: PubMed PMID 19596825